NMN (Nicotinamide Mononucleotide) vs Resveratrol

Side-by-side comparison of evidence grade, dosage, safety, and stacking compatibility.

Combined: Synergistic ✦The classic Sinclair protocol. Take together in the morning with a fat source fo

Overview

A nucleotide precursor that replenishes cellular NAD+ levels, which decline significantly with age. Among the most-researched longevity compounds with human clinical trial data.

Summary

A polyphenolic stilbenoid found in red wine and grape skins that activates SIRT1 and AMPK pathways. Requires NAD+ co-factors for maximal sirtuin activation, making it synergistic with NMN.
NAD+ Precursor

Category

Polyphenol / Sirtuin Activator
B

Evidence Grade

A = strongest

B
Tier A — Proven

Safety Tier

A = safest

Tier A — Proven

Dosage

500 mg/day

Typical Dose

500 mg/day
250–1000 mg

Low / High

100–1000 mg
Morning, fasted or with a light breakfast

Timing

Morning with breakfast containing fat (improves absorption 5-fold)
5 days on, 2 days off (optional cycling protocol)

Cycling

Continuous use acceptable; some protocols use 5-on/2-off

Goals & Use Cases

longevityenergycellular-repair

Primary Goals

longevitycardiovascularanti-inflammatory
Shared goals:longevity

Safety Profile

  • Active cancer treatment (consult oncologist first)
  • Pregnancy or breastfeeding (insufficient safety data)

Contraindications

fewer = safer

A wins
  • Blood-thinning medications (warfarin, aspirin) — may potentiate anticoagulant effect
  • Hormone-sensitive cancers (oestrogen-receptor positive)
  • Pregnancy — insufficient safety data

Regulatory Status

✓ Legal

Legal (US)

✓ Legal
✓ Legal

Legal (EU)

✓ Legal

Can you take NMN (Nicotinamide Mononucleotide) and Resveratrol together?

Synergistic ✦

The classic Sinclair protocol. Take together in the morning with a fat source for better resveratrol absorption.

NMN raises NAD+ levels; Resveratrol activates SIRT1 which requires NAD+ as a cofactor. Together they produce synergistic sirtuin pathway activation and mitochondrial biogenesis.